| Financial Year |
March 31 2023 |
| Monetary Funds |
1,576,505,371.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,123,926,817.40 |
| Advances to Suppliers |
36,972,585.21 |
| Other Receivables |
397,146,820.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
166,657,342.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,839,799.34 |
| Total Current Assets |
3,329,834,283.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
80,307,658.80 |
| Fixed Assetes |
890,408,584.12 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
27,028,585,481.82 |
| Intangible Assets |
26,424,333.32 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
58,292,069.58 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
28,197,215,518.65 |
| Total Assets |
31,527,049,801.91 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
987,104,671.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
113,560,309.34 |
| Taxes Payable |
76,836,281.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,290,120,185.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
211,955,158.96 |
| Other Current Liabilities |
76,047,277.47 |
| Sub-Total of Current Liabilities |
2,755,623,883.73 |
| Long-term Loans |
-- |
| Bonds Payable |
7,692,796,071.16 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,509,963,300.60 |
| Deferred Income Tax Liabilities |
1,965,433,599.53 |
| Other Non-Current Liabilities |
3,429,946.43 |
| Sub-Total of Non-Current Liabilities |
11,297,334,630.66 |
| Total Liabilities |
14,052,958,514.39 |
| Paid-In Capital(Or Share Stock) |
6,800,495,825.00 |
| Capital Surplus |
6,657,204,139.08 |
| Surplus Reserve |
92,923,435.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,334,817,824.60 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,474,091,287.52 |
| Owner's Equity（Stockholder's Equity） |
17,474,091,287.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,527,049,801.91 |
